Kruisbergen Nik N L, Di Ceglie Irene, van Gemert Yvonne, Walgreen Birgitte, Helsen Monique M A, Slöetjes Annet W, Koenders Marije I, van de Loo Fons A J, Roth Johannes, Vogl Thomas, van der Kraan Peter M, Blom Arjen B, van Lent Peter L E M, van den Bosch Martijn H J
Experimental Rheumatology, Department of Rheumatology, Radboud University Medical Center, 6525GA Nijmegen, The Netherlands.
Institute of Immunology, University of Münster, 48149 Muenster, Germany.
Antioxidants (Basel). 2021 Oct 22;10(11):1660. doi: 10.3390/antiox10111660.
Osteoarthritis (OA) is a destructive disease of the joint with age and obesity being its most important risk factors. Around 50% of OA patients suffer from inflammation of the synovial joint capsule, which is characterized by increased abundance and activation of synovial macrophages that produce reactive oxygen species (ROS) via NADPH-oxidase 2 (NOX2). Both ROS and high blood levels of low-density lipoprotein (LDL) are implicated in OA pathophysiology, which may interact to form oxidized LDL (oxLDL) and thereby promote disease. Therefore, targeting NOX2 could be a viable treatment strategy for OA. Collagenase-induced OA (CiOA) was used to compare pathology between wild-type (WT) and Nox2 knockout () C57Bl/6 mice. Mice were either fed a standard diet or Western diet (WD) to study a possible interaction between NOX2-derived ROS and LDL. Synovial inflammation, cartilage damage and ectopic bone size were assessed on histology. Extracellular ROS production by macrophages was measured in vitro using the Amplex Red assay. macrophages produced basal levels of ROS but were unable to increase ROS production in response to the alarmin S100A8 or the phorbol ester PMA. Interestingly, deficiency reduced cartilage damage, synovial lining thickness and ectopic bone size, whereas these disease parameters were not affected by WD-feeding. These results suggest that NOX2-derived ROS are involved in CiOA development.
骨关节炎(OA)是一种关节破坏性疾病,年龄和肥胖是其最重要的风险因素。约50%的OA患者患有滑膜关节囊炎症,其特征是滑膜巨噬细胞数量增加且被激活,这些巨噬细胞通过烟酰胺腺嘌呤二核苷酸磷酸氧化酶2(NOX2)产生活性氧(ROS)。ROS和血液中高水平的低密度脂蛋白(LDL)都与OA的病理生理过程有关,它们可能相互作用形成氧化型LDL(oxLDL),从而促进疾病发展。因此,靶向NOX2可能是一种可行的OA治疗策略。采用胶原酶诱导的骨关节炎(CiOA)来比较野生型(WT)和Nox2基因敲除()C57Bl/6小鼠的病理情况。给小鼠喂食标准饮食或西式饮食(WD),以研究NOX2衍生的ROS与LDL之间可能的相互作用。通过组织学评估滑膜炎症、软骨损伤和异位骨大小。使用Amplex Red检测法在体外测量巨噬细胞产生的细胞外ROS。巨噬细胞产生基础水平的ROS,但对警报素S100A8或佛波酯PMA无反应,无法增加ROS的产生。有趣的是,基因敲除减少了软骨损伤、滑膜衬里厚度和异位骨大小,而这些疾病参数不受WD喂养的影响。这些结果表明,NOX2衍生的ROS参与了CiOA的发展。